These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 33631387

  • 1. Role of Cilostazol in Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage-A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
    Bohara S, Garg K, Singh Rajpal PM, Kasliwal M.
    World Neurosurg; 2021 Jun; 150():161-170. PubMed ID: 33631387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
    Senbokuya N, Kinouchi H, Kanemaru K, Ohashi Y, Fukamachi A, Yagi S, Shimizu T, Furuya K, Uchida M, Takeuchi N, Nakano S, Koizumi H, Kobayashi C, Fukasawa I, Takahashi T, Kuroda K, Nishiyama Y, Yoshioka H, Horikoshi T.
    J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen J, Shen J, Zhu K, Zhou H, Tian H, Yu G.
    World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of Cilostazol in Animal Models of Cerebral Ischemia and Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.
    Qureshi AI, Akhtar IN, Ma X, Lodhi A, Bhatti I, Beall J, Broderick JP, Cassarly CN, Martin RH, Sharma R, Thakkar M, Suarez JI.
    Neurocrit Care; 2023 Jun; 38(3):698-713. PubMed ID: 36450971
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.
    Dayyani M, Sadeghirad B, Grotta JC, Zabihyan S, Ahmadvand S, Wang Y, Guyatt GH, Amin-Hanjani S.
    Stroke; 2022 Jun; 53(6):1993-2005. PubMed ID: 35354302
    [Abstract] [Full Text] [Related]

  • 11. Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.
    Boulouis G, Labeyrie MA, Raymond J, Rodriguez-Régent C, Lukaszewicz AC, Bresson D, Ben Hassen W, Trystram D, Meder JF, Oppenheim C, Naggara O.
    Eur Radiol; 2017 Aug; 27(8):3333-3342. PubMed ID: 28004163
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cilostazol Administration for Subarachnoid Hemorrhage: A Meta-analysis of Randomized Controlled Trials.
    Chen H, Luo W, Cai X, Cai J.
    Clin Neuropharmacol; 2017 Aug; 45(5):111-116. PubMed ID: 36162042
    [Abstract] [Full Text] [Related]

  • 15. Dose-Dependent Inhibitory Effects of Cilostazol on Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage.
    Suzuki H, Nakatsuka Y, Yasuda R, Shiba M, Miura Y, Terashima M, Suzuki Y, Hakozaki K, Goto F, Toma N.
    Transl Stroke Res; 2019 Aug; 10(4):381-388. PubMed ID: 30033486
    [Abstract] [Full Text] [Related]

  • 16. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J, Huang KY, Zhu Y, Pan JW, Jiang H, Weng YX, Zhan RY.
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic Benefit of Cilostazol in Patients with Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized and Nonrandomized Studies.
    Qureshi AI, Ishfaq A, Ishfaq MF, Pandhi A, Ahmed SI, Singh S, Kerro A, Krishnan R, Deep A, Georgiadis AL.
    J Vasc Interv Neurol; 2018 Nov; 10(2):33-40. PubMed ID: 30746008
    [Abstract] [Full Text] [Related]

  • 18. Cilostazol administration for subarachnoid hemorrhage: A meta-analysis of randomized controlled trials.
    Chen J, Tang P, Fu X.
    J Clin Neurosci; 2021 Jul; 89():305-310. PubMed ID: 34119285
    [Abstract] [Full Text] [Related]

  • 19. Effect of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Niu PP, Yang G, Xing YQ, Guo ZN, Yang Y.
    J Neurol Sci; 2014 Jan 15; 336(1-2):146-51. PubMed ID: 24211059
    [Abstract] [Full Text] [Related]

  • 20. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
    Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O, Tominaga T.
    J Neurosurg; 2022 Dec 01; 137(6):1707-1717. PubMed ID: 35364589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.